Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKD 1.16

(0.0%)

Long Term Debt Summary of Dawnrays Pharmaceutical (Holdings) Limited

Dawnrays Pharmaceutical (Holdings) Limited's latest annual long term debt in 2023 was 103 Thousand CNY , down -76.8% from previous year.
Dawnrays Pharmaceutical (Holdings) Limited's latest quarterly long term debt in 2023 FY was 103 Thousand CNY , down -76.8% from previous quarter.
Dawnrays Pharmaceutical (Holdings) Limited reported annual long term debt of 444 Thousand CNY in 2022, down -70.92% from previous year.
Dawnrays Pharmaceutical (Holdings) Limited reported annual long term debt of 1.52 Million CNY in 2021, down -24.59% from previous year.
Dawnrays Pharmaceutical (Holdings) Limited reported quarterly long term debt of 103 Thousand CNY for 2023 FY, down -76.8% from previous quarter.
Dawnrays Pharmaceutical (Holdings) Limited reported quarterly long term debt of 103 Thousand CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Historical Annual Long Term Debt of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Year	Long Term Debt	Long Term Debt Growth
2023	103 Thousand CNY	-76.8%
2022	444 Thousand CNY	-70.92%
2021	1.52 Million CNY	-24.59%
2020	2.02 Million CNY	-28.72%
2019	2.84 Million CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	100.0%
2015	-2.68 Million CNY	22.79%
2014	-3.47 Million CNY	10.53%
2013	-3.88 Million CNY	-85.48%
2012	-2.09 Million CNY	0.0%
2011	- CNY	0.0%
2010	- CNY	-100.0%
2009	3.52 Million CNY	0.0%
2008	- CNY	0.0%
2007	- CNY	0.0%
2006	- CNY	0.0%
2005	- CNY	0.0%
2004	- CNY	0.0%
2003	- CNY	0.0%
2002	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q2	113 Thousand CNY	0.0%
2023 FY	103 Thousand CNY	-76.8%
2023 Q4	103 Thousand CNY	0.0%
2022 Q2	995 Thousand CNY	0.0%
2022 Q4	444 Thousand CNY	0.0%
2022 FY	444 Thousand CNY	-70.92%
2021 Q4	1.52 Million CNY	0.0%
2021 FY	1.52 Million CNY	-24.59%
2021 Q2	1.61 Million CNY	0.0%
2020 Q2	2.42 Million CNY	0.0%
2020 FY	2.02 Million CNY	-28.72%
2020 Q4	2.02 Million CNY	0.0%
2019 Q4	2.84 Million CNY	0.0%
2019 Q2	2.66 Million CNY	0.0%
2019 FY	2.84 Million CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q2	- CNY	0.0%
2018 FY	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q2	- CNY	0.0%
2017 Q4	- CNY	0.0%
2016 Q4	- CNY	0.0%
2016 Q2	-2.68 Million CNY	0.0%
2016 FY	- CNY	100.0%
2015 Q4	-2.68 Million CNY	0.0%
2015 FY	-2.68 Million CNY	22.79%
2015 Q2	-3.47 Million CNY	0.0%
2014 Q2	-3.88 Million CNY	0.0%
2014 FY	-3.47 Million CNY	10.53%
2014 Q4	-3.47 Million CNY	0.0%
2013 Q2	-3.59 Million CNY	0.0%
2013 FY	-3.88 Million CNY	-85.48%
2013 Q4	-3.88 Million CNY	0.0%
2012 Q4	-2.09 Million CNY	0.0%
2012 FY	-2.09 Million CNY	0.0%
2012 Q2	- CNY	0.0%
2011 Q2	- CNY	0.0%
2011 FY	- CNY	0.0%
2011 Q4	- CNY	0.0%
2010 FY	- CNY	-100.0%
2010 Q2	2.61 Million CNY	0.0%
2010 Q4	- CNY	0.0%
2009 FY	3.52 Million CNY	0.0%
2009 Q4	3.52 Million CNY	0.0%
2009 Q2	- CNY	0.0%
2008 FY	- CNY	0.0%
2008 Q4	- CNY	0.0%
2007 FY	- CNY	0.0%
2006 FY	- CNY	0.0%
2005 FY	- CNY	0.0%
2004 FY	- CNY	0.0%
2003 FY	- CNY	0.0%
2002 FY	- CNY	0.0%

Peer Long Term Debt Comparison of Dawnrays Pharmaceutical (Holdings) Limited

Name	Long Term Debt	Long Term Debt Difference
Pak Fah Yeow International Limited	2.07 Million HKD	95.031%
Grand Pharmaceutical Group Limited	990.02 Million HKD	99.99%
Extrawell Pharmaceutical Holdings Limited	117.12 Million HKD	99.912%
Wai Yuen Tong Medicine Holdings Limited	276.2 Million HKD	99.963%
Qianhai Health Holdings Limited	- HKD	-Infinity%
Lee's Pharmaceutical Holdings Limited	70.63 Million HKD	99.854%
Essex Bio-Technology Limited	36.05 Million HKD	99.714%
Tongfang Kontafarma Holdings Limited	12.8 Million HKD	99.195%
PuraPharm Corporation Limited	81.09 Million HKD	99.873%
SSY Group Limited	1.94 Billion HKD	99.995%
JBM (Healthcare) Limited	43.8 Million HKD	99.765%
Jacobson Pharma Corporation Limited	592.2 Million HKD	99.983%
China Resources Pharmaceutical Group Limited	16.61 Billion HKD	99.999%